Norland signs new densitometer deal

Article

After terminating a two-year alliance with Canadian firm IMRO, bone densitometry vendor Norland has found a new partner for an ultrasound densitometer unit. The White Plains, NY, company in June acquired rights to distribute and service an ultrasound

After terminating a two-year alliance with Canadian firm IMRO, bone densitometry vendor Norland has found a new partner for an ultrasound densitometer unit. The White Plains, NY, company in June acquired rights to distribute and service an ultrasound bone measurement system developed by U.K. firm McCue.

The June 17 agreement gives Norland the right to distribute McCue’s CubaClinical system in Canada, parts of Europe, the Middle East, and the Pacific Rim. The company will distribute and service the system in the U.S. once it has received clearance from the Food and Drug Administration, which McCue expects later this year. CubaClinical is a dry system and boasts a large clinical database, according to Norland executives.

Norland signed a deal with IMRO in 1997 for rights to distribute IMRO’s existing ultrasound bone measurement system, which Norland called Paris (SCAN 2/18/98 and 9/17/97). Norland began shipping Paris to European and Pacific Rim clients last year, but when Paris didn’t receive PMA clearance in the U.S. as Norland had expected, the company ended its alliance with IMRO.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.